These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 12552235

  • 1. Pharmacokinetics studies and toxicity profile of raltitrexed used by intraperitoneal route in normothermia in a pig model.
    Nguyen D, Emond C, Leclerc Y, Sherman I, Dube P.
    Med Sci Monit; 2003 Jan; 9(1):BR37-42. PubMed ID: 12552235
    [Abstract] [Full Text] [Related]

  • 2. A study of the effect of temperature on the pharmacokinetic profile of raltitrexed administered by intraperitoneal route in the rat.
    Bendavid Y, Leblond FA, Dubé P.
    Med Sci Monit; 2005 Jan; 11(1):BR1-5. PubMed ID: 15614183
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
    Blair EY, Rivory LP, Clarke SJ, McLachlan AJ.
    Br J Clin Pharmacol; 2004 Apr; 57(4):416-26. PubMed ID: 15025739
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The importance of p53-independent apoptosis in the intestinal toxicity induced by raltitrexed (ZD1694, Tomudex): genetic differences between BALB/c and DBA/2 mice.
    Pritchard DM, Bower L, Potten CS, Jackman AL, Hickman JA.
    Clin Cancer Res; 2000 Nov; 6(11):4389-95. PubMed ID: 11106258
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical and preclinical pharmacokinetics of raltitrexed.
    Clarke SJ, Beale PJ, Rivory LP.
    Clin Pharmacokinet; 2000 Dec; 39(6):429-43. PubMed ID: 11192475
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program.
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [Abstract] [Full Text] [Related]

  • 13. Potential and toxicity of intravesical pemetrexed: a preclinical study in pigs.
    Hendricksen K, Moonen PM, van der Heijden AG, Molkenboer-Kuenen J, Hulsbergen-van de Kaa CA, Witjes JA.
    Clin Cancer Res; 2006 Apr 15; 12(8):2597-601. PubMed ID: 16638871
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
    Dunnick J.
    Toxic Rep Ser; 2002 Nov 15; (70):5-51. PubMed ID: 12592414
    [Abstract] [Full Text] [Related]

  • 18. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model.
    Glehen O, Stuart OA, Mohamed F, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2004 Jul 15; 54(1):79-84. PubMed ID: 15048586
    [Abstract] [Full Text] [Related]

  • 19. Hepatic Artery and Peripheral Vein Pharmacokinetics of Raltitrexed in Swine After the Administration of a Hepatic Arterial Infusion.
    Zhu L, Zheng N, Li X, Zhang X.
    Curr Drug Metab; 2019 Jul 15; 20(7):601-608. PubMed ID: 31237202
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of infusional biomodulated 5-fluorouracil in metastatic colorectal cancer after raltitrexed failure.
    Decoster L, Neyns B, Akouaouach H, Fontaine C, Schallier D, De Grève JL.
    Anticancer Res; 2004 Jul 15; 24(3b):2037-40. PubMed ID: 15274397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.